CEPHA Biotech

CEPHA Biotech creates solutions for the democratization of molecular testing. The startup developed OmniLAMP, a portable device currently used for molecular diagnosis of COVID-19, and MyTest, a rapid test also for Covid-19 done with saliva. In addition, the startup develops customized solutions for DNA detection in the areas of human and animal health, agriculture and the environment, and has focused its efforts on improving a solution for real-time monitoring of the appearance of SARS-CoV-2.

BUSINESS MODEL: B2B offering service and training for partners and customers

PRODUCT: OmniLamp and MyTest complete

Other products in development

STAGE: Sales and commercial approval

For further information, please contact us.

Back to Investors page